Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Chemical Earnings

Higher prices and volumes continue to drive improvement in results

by WILLIAM STORCK
January 31, 2005 | A version of this story appeared in Volume 83, Issue 5

BUSINESS

Early results from chemical companies indicate that the fourth quarter of 2004 continued the industry's streak of sales and earnings improvement. All eight chemical firms that have published their results have shown at least double-digit growth over the same period in 2003.

The largest percentage gain was at Monsanto, which, after taking out a number of unusual charges, managed to increase its earnings from continuing operations to $35.0 million, 236.5% above the fourth-quarter-2003 level. Sales at the company were up just 6.8% to $1.10 billion. CEO Hugh Grant says, "The value of our seeds and [biotech] traits business is growing globally." He adds that the company saw good early performance in the quarter not only in the U.S., but also in Brazil, Europe, and Australia.

Industry leader Dow Chemical had the largest dollar earnings growth among the companies--$348.0 million, or 73.3%, to $823.0 million. Sales were up 31.3% to $10.9 billion. CEO Andrew N. Liveris explains: "In part, the margin expansion was driven by the improvement we saw in industry fundamentals. But price/volume management and our ongoing commitment to controlling costs were equally important contributors."

Number two DuPont saw earnings increase 25.3% to $371.0 million. While sales at the company declined 7.4% to $6.0 billion, when the company's divested textile and interiors business is excluded from fourth-quarter 2003, total comparable segment sales were up 14%. The company notes that all of its segments showed growth in pretax income.

Another big gainer during the quarter was Cytec Industries, where earnings almost doubled, rising 91.8% to $28.0 million, and sales increased 24.5% to $450.6 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.